Qube Research & Technologies (QRT)
IMUX icon

Qube Research & Technologies (QRT)’s Immunic IMUX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.37M Buy
+147,577
New +$2.03M ﹤0.01% 2484
2026
Q2 		– Sell
-11,146
Closed -$124K – 3761
2026
Q1 		$124K Buy
+11,146
New +$100K ﹤0.01% 3039
2025
Q4 		– Sell
-3,267
Closed -$28.8K – 3860
2025
Q3 		$28.8K Buy
+3,267
New +$28.8K ﹤0.01% 3256
2025
Q2 		– Sell
-3,499
Closed -$38.1K – 3737
2025
Q1 		$38.1K Sell
3,499
-13,077
-79% -$141K ﹤0.01% 3155
2024
Q4 		$166K Sell
16,576
-920
-5% -$11.6K ﹤0.01% 2880
2024
Q3 		$289K Buy
17,496
+17,491
+349,820% +$249K ﹤0.01% 2441
2024
Q2 		$56 Buy
+5
New +$62 ﹤0.01% 3495
2024
Q1 		– Sell
-6
Closed -$87 – 4665
2023
Q4 		$87 Hold
6
– – ﹤0.01% 4034
2023
Q3 		$85 Buy
+6
New +$115 ﹤0.01% 3776
2022
Q4 		– Sell
-1,434
Closed -$45K – 2722
2022
Q3 		$45K Sell
1,434
-137
-9% -$5.73K ﹤0.01% 2158
2022
Q2 		$55K Buy
+1,571
New +$101K ﹤0.01% 2101

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMUX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Immunic (IMUX) in Q3 2026: 147,577 shares worth $1.37M. The stake represents ﹤0.01% of the portfolio and ranks #2484 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IMUX as recently as Q1 2026.

Qube Research & Technologies (QRT) first reported a position in IMUX in Q2 2022 and has held it in 11 quarters since. 49 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • Qube Research & Technologies (QRT) held 147,577 shares of Immunic worth $1.37M as of Q3 2026.
  • Immunic was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Immunic made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2484 holding.
  • Qube Research & Technologies (QRT) first reported a position in Immunic in Q2 2022 and has held it in 11 quarters since.
  • 49 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.